Cargando…

Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature

Angiogenesis inhibitors such as tyrosine kinase inhibitors (TKIs) are common therapeutics currently used to treat oncologic disease. Surufatinib is a novel, small-molecule multiple receptor TKI approved by the National Medical Products Administration (NMPA) for the treatment of progressive, advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wenjiao, Wang, Wei, Shi, Yuanping, Shen, Bo, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611822/ https://www.ncbi.nlm.nih.gov/pubmed/37101053 http://dx.doi.org/10.1007/s00428-023-03545-2

Ejemplares similares

Cabozantinib‐induced renal thrombotic microangiopathy
por: La Manna, Gaetano, et al.
Publicado: (2017)

Nintedanib-Induced Renal Thrombotic Microangiopathy
por: Fujita, Takeshi, et al.
Publicado: (2021)

Gemcitabine-Induced Renal Thrombotic Microangiopathy
por: Chaudhary, Ankur, et al.
Publicado: (2023)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Renal thrombotic microangiopathy induced by β-interferon
por: Li Cavoli, Gioacchino, et al.
Publicado: (2011)

Regorafenib-induced renal-limited thrombotic microangiopathy: a case report and review of literatures
por: Yin, Qinghua, et al.
Publicado: (2022)

The spectrum of renal thrombotic microangiopathy in lupus nephritis
por: Song, Di, et al.
Publicado: (2013)

Thrombotic microangiopathy and associated renal disorders*
por: Barbour, Thomas, et al.
Publicado: (2012)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

The efficacy of oxaliplatin, surufatinib, and camrelizumab on neuroendocrine carcinoma: a case report and literature review
por: Wang, Xianhua, et al.
Publicado: (2022)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review
por: Kong, Weiwei, et al.
Publicado: (2022)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Thrombotic microangiopathy with severe renal failure in adenocarcinoma
por: Lakshminarayana, G., et al.
Publicado: (2008)

Progressive bevacizumab-associated renal thrombotic microangiopathy*
por: Uy, Alice L., et al.
Publicado: (2009)

Snakebite Induced Thrombotic Microangiopathy Leading to Renal Cortical Necrosis
por: Gn, Ying Mao, et al.
Publicado: (2017)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Tacrolimus: Thrombotic microangiopathy: case report
Publicado: (2021)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

An Update in Drug-Induced Thrombotic Microangiopathy
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2020)

Perindopril/amlodipine-induced thrombotic microangiopathy
por: Periša, Vlatka, et al.
Publicado: (2020)

Oxaliplatin-induced thrombotic microangiopathy: a case report
por: Saad, Rhea, et al.
Publicado: (2022)

Glucocorticoid-induced thrombotic microangiopathy in paroxysmal nocturnal hemoglobinuria: A case report and review of literature
por: Yang, Xiao-Dong, et al.
Publicado: (2023)

Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report
por: Ventura, Sofia, et al.
Publicado: (2022)

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies
por: Hofer, Johannes, et al.
Publicado: (2014)

Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
por: Saba, Ludovic, et al.
Publicado: (2022)

Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle
por: Wehrmann, Florian, et al.
Publicado: (2023)

Dengue Fever-induced Thrombotic Microangiopathy: An Unusual Cause of Renal Failure
por: Bhargava, V., et al.
Publicado: (2017)

Hypertension-Induced Thrombotic Microangiopathy Leading to End-Stage Renal Disease
por: Juarez, Angel, et al.
Publicado: (2023)

Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017)

Is thrombotic microangiopathy a paraneoplastic phenomenon? Case report and review of the literature
por: Houston, Simon A., et al.
Publicado: (2011)

Pulmonary Tumor Thrombotic Microangiopathy: Report of 3 Cases and Review of the Literature
por: Gainza, Eukene, et al.
Publicado: (2014)

Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review
por: Mocanu, Adriana, et al.
Publicado: (2023)

Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review
por: Filippone, Edward J., et al.
Publicado: (2021)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)
por: Xu, Jianming
Publicado: (2021)

A rare case report of gemcitabine-induced thrombotic microangiopathies
por: Madkhali, Mohammed Ali
Publicado: (2021)

Tacrolimus: Transient thrombotic microangiopathy: case report
Publicado: (2020)

Pneumococcal Induced T-activation with Resultant Thrombotic Microangiopathy
por: Oliver, J.W., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dgb94k2ktfniidci85m3fu4pcd